BioCentury
ARTICLE | Clinical News

Extended release tramadol: CLC's Cipher Pharmaceuticals Inc. subsidiary submitted an IND to begin U.S. and Canadian Phase II testing of its once-daily tramadol

January 22, 2002 8:00 AM UTC

Canadian Medical Laboratories Ltd. (TSE:CLC), Mississauga, Ontario Product: Extended release tramadol Business: Neurological Therapeutic category: Analgesic, Neurotransmission Target: Opioid receptor...